Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-27T21:49:19.597Z Has data issue: false hasContentIssue false
  • English
  • Français

UPDATE ON THE NEW MODALITIES ON THE PREVENTION AND MANAGEMENT OF POSTPARTUM HAEMORRHAGE

Published online by Cambridge University Press:  24 October 2011

GHADA ABOU EL SENOUN ,
MANDEEP SINGH ,
HATEM A. MOUSA  and
ZARKO ALFIREVIC
GHADA ABOU EL SENOUN
Affiliation:
Department of Obstetrics and Gynaecology, Chesterfield Hospital, United Kingdom.
MANDEEP SINGH
Affiliation:
Fetal and Maternal Medicine, University Hospital Leicester, United Kingdom.
HATEM A. MOUSA*
Affiliation:
Fetal and Maternal Medicine, University Hospital Leicester, United Kingdom.
ZARKO ALFIREVIC
Affiliation:
Department of Women's and Children's Health, University of Liverpool, United Kingdom.
*
Hatem Mousa, Consultant Fetal and Maternal Medicine, University Hospital Leicester, United Kingdom. Email: mousa339@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Extract

Some half a million women die annually across the world from causes related to pregnancy and childbirth. Approximately one-quarter of these deaths are caused by complications of the third stage of labour, mainly postpartum haemorrhage (PPH). In the developing world, the risk of maternal death from PPH is approximately one in 1000 deliveries. In the United Kingdom the risk of maternal death from obstetric haemorrhage is about 0.39 in 100000 deliveries.

Type
Review Article
Information
Fetal and Maternal Medicine Review , Volume 22 , Issue 4 , November 2011 , pp. 247 - 264
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1Adamson, P. A failure of imagination. Progress of Nations. UNICEF; 1996: 2–9.Google Scholar
2The prevention and management of postpartum haemorrhage. WHO report of technical working group. Geneva: World Health Organization; 1990. Report No. WHO/MCH/90.7.Google Scholar
3Abouzahr C. Antepartum and postpartum haemorrhage. In: Murray, CJL, Lopez, AD (eds) Health dimensions of sex and reproduction; 1998; Boston, Harvard University Press: 172–174.Google Scholar
4Abou Zahr, C, Royston, E.Global mortality: Global fact book. Geneva: World Health Organisation; 1991.Google Scholar
5Cantwell, R, Clutton-Brock, T, Cooper, G, Dawson, A, Drife, J, Garrod, D et al. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. BJOG 2011: 118: S:1:1–203.Google ScholarPubMed
6Begley, CM, Gyte, GML, Murphy, DJ, Devane, D, McDonald, SJ, McGuire, W. Active versus expectant management for women in the third stage of labour. Cochrane Database of Syst Rev 2010: 7: CD007412.Google Scholar
7McDonald, SJ, Abbott, JM, Higgins, SP. Prophylactic ergometrine - oxytocin versus oxytocin for the third stage of labour. Cochrane Database of Syst Rev 2004: 1: CD000201.Google Scholar
8Gülmezoglu, AM, Villar, J, Ngoc, NT, Piaggio, G, Carroli, G, Adetoro, L et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001; 358: 689–695.CrossRefGoogle ScholarPubMed
9Hofmeyr, GJ, Gülmezoglu, AM. Misoprostol for the prevention and treatment of postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008; 22: 1025–41.CrossRefGoogle ScholarPubMed
10Mousa, HA, Alfirevic, Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2007; 24; 1: CD003249.Google Scholar
11Blum, J, Winikoff, B, Raghavan, S, Dabash, R, Ramadan, MC, Dilbaz, B et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet 2010: 16: 217–23.CrossRefGoogle Scholar
12Postpartum Haemorrhage, Prevention and Management Royal College of Obstetricians and Gynaecologists green-top Guideline No. 52.Google Scholar
13Hofmeyr, GJ, Gülmezoglu, AM, Novikova, N, Linder, V, Ferreira, S, Piaggio, G. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ. 2009; 87: 666–77.CrossRefGoogle ScholarPubMed
14Sweeney, G, Holbrook, AM, Levine, M, Yip, M, Alfredsson, K, Cappi, S et al. Pharmacokinetics of carbetocin, a long-acting oxytocin analogue in non pregnant women. Curr Ther Res 1990; 47: 520–40.Google Scholar
15Hunter, DJ, Schulz, P, Wassenaar, W. Effect of carbetocin, a long acting oxytocin analogue in the postpartum uterus. Clin Pharmacol Ther 1992; 52: 60–67.CrossRefGoogle ScholarPubMed
16Su, LL, Chong, YS, Samuel, M. Oxytocin agonists for preventing postpartum haemorrhage. Cochrane Database of Syst Rev 2007: 3; CD005457.Google Scholar
17Peters, NC, Duvekot, JJ. Carbetocin for the prevention of postpartum hemorrhage: a systematic review. Obstet Gynecol Surv 2009; 64: 129–35.CrossRefGoogle ScholarPubMed
18Nirmala, K, Zainuddin, AA, Ghani, NA, Zulkifli, S, Jamil, MA. Carbetocin versus syntometrine in prevention of post-partum hemorrhage following vaginal delivery. J Obstet Gynaecol Res 2009: 35: 48–54.CrossRefGoogle ScholarPubMed
19Attilakos, G, Psaroudakis, D, Ash, J, Buchanan, R, Winter, C, Donald, F et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG 2010; 17: 929–36.CrossRefGoogle Scholar
20Su, LL, Rauff, M, Chan, YH, Mohamad Suphan, N, Lau, TP, Biswas, A, Chong, YS. Carbetocin versus syntometrine for the third stage of labour following vaginal delivery–a double-blind randomised controlled trial. BJOG 2009; 116; 1461–466.CrossRefGoogle ScholarPubMed
21Borruto, F, Treisser, A, Comparetto, C. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Arch Gynecol Obstet 2009; 280: 707–12.CrossRefGoogle ScholarPubMed
22Ngan, L, Keong, W, Martins, R. Carbetocin versus a combination of oxytocin and ergometrine in control of postpartum blood loss. Int J Gynaecol Obstet 2007; 97: 152–53.CrossRefGoogle ScholarPubMed
23Rath, W. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin. Eur J Obstet Gynecol Reprod Biol 2009; 147: 15–20.CrossRefGoogle ScholarPubMed
24Del-Angel-García, G, García-Contreras, F, Constantino-Casas, P, Nevarez-Sida, A, Lopez-Gonzales, N, Garcia-Constantino, M et al. Economic evaluation of carbetocine for the prevention of uterine atony in patients with risk factors in Mexico. Value Health 2006; 9: A254.CrossRefGoogle Scholar
25Novikova, N, Hofmeyr, GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Syst Rev 2010; Issue 7. CD007872.CrossRefGoogle Scholar
26Ferrer, P, Roberts, I, Sydenham, E, Blackhall, K, Shakur, H. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth. 2009; 15; 29.CrossRefGoogle Scholar
27Gai, MY, Wu, LF, Su, QF, Tatsumoto, K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 2004; 112: 154–57.CrossRefGoogle ScholarPubMed
28Yang, H, Zheng, S, Shi, C. Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized comparative, multicenter trial. Chung-Hua Fu Chan Ko Tsa Chih 2001; 36: 590–92.Google Scholar
29Gohel, M, Patel, P, Ashoo, G, Desai, P. Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: A randomised case controlled prospective study. J Obstet Gynecol India 2007; 57: 227–30.Google Scholar
30Ferrer, P, Roberts, I, Sydenham, E, Blackhall, K, Shakur, H. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth 2009; 15; 29.CrossRefGoogle Scholar
31Peitsidis, P, Kadir, RA. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother 2011; 12: 503–16.CrossRefGoogle ScholarPubMed
32Shakur, H, Elbourne, D, Gülmezoglu, M, Alfirevic, Z, Ronsmans, C, Allen, E, Roberts, I. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010; 11: 40.CrossRefGoogle ScholarPubMed
33Franchini, M, Franchi, M, Bergamini, V, Montagnana, M, Salvagno, GL, Targher, G, Lippi, G.Clin Obstet Gynecol 2010; 53: 219–27.CrossRefGoogle Scholar
34Recombinant human activated factor VII as salvage therapy in women with severe postpartum haemorrhage. Available at; http://clinicaltrials.gov/ct/show/NCT00370877.Google Scholar
35Franchini, M, Franchi, M, Bergamini, V, Montagnana, M, Salvagno, G, Targher, G et al. Clin Obstet Gynecol 2010; 53: 219–27.CrossRefGoogle Scholar
36Georgiou, C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG 2009; 116: 748–57.CrossRefGoogle ScholarPubMed
37Doumouchtsis, SK, Papageorghiou, AT, Arulkumaran, S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv 2007; 62: 540–47.CrossRefGoogle Scholar
38Condous, GS, Arulkumaran, S, Symonds, I, Chapman, R, Sinha, A, Razvi, K. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet Gynecol 2003; 101: 767–72.Google Scholar
39Frenzel, D, Condous, GS, Papageorghiou, AT, McWhinney, NA. The use of the “tamponade test” to stop massive obstetric haemorrhage in placenta accreta. BJOG 2005; 112: 676–77.CrossRefGoogle Scholar
40Tattersall, M, Braithwaite, W. Balloon tamponade for vaginal lacerations causing severe postpartum haemorrhage. BJOG 2007; 114: 647–48.CrossRefGoogle ScholarPubMed
41Yoong, W, Ray, A, Phillip, SA. Balloon tamponade for postpartum vaginal lacerations in a woman refusing blood transfusion. Int J Gynaecol Obstet 2009; 106: 261.CrossRefGoogle Scholar
42Palacios-Jaraquemada, J, Fiorillo, A. Conservative approach in heavy postpartum hemorrhage associated with coagulopathy. Acta Obstet Gynecol Scand 2010; 89: 1222–225.CrossRefGoogle ScholarPubMed
43Anorlu, RI, Maholwana, B, Hofmeyr, GJ. Methods of delivering the placenta at caesarean section. Cochrane Database Syst Rev 2008:16;3: CD004737.Google Scholar
44Magann, EF, Chauhan, SP, Bufkin, L, Field, K, Roberts, WE, Martin, JN Jr. Intra-operative haemorrhage by blunt versus sharp expansion of the uterine incision at caesarean delivery: a randomised clinical trial. BJOG 2002; 10: 448–52.Google Scholar
45Fuglsang, K, Petersen, LK. New local haemostatic treatment for postpartum hemorrhage caused by placenta praevia at cesarean section. Acta Obstet Gynecol Scand 2010; 89: 1346–349.CrossRefGoogle ScholarPubMed
46Dhulkotia, JS, Alazzam, M, Galimberti, A. Tisseel for management of traumatic postpartum haemorrhage. Arch Gynecol Obstet 2009; 279: 437–39.CrossRefGoogle ScholarPubMed
47Kayem, G, Kurinczuk, J, Alfirevic, Z, Spark, P, Brocklehurst, P, Knight, M. Specific second-line therapies for postpartum haemorrhage: a national cohort study. BJOG 2011; 118: 856–64.CrossRefGoogle ScholarPubMed
48Grotegut, CA, Larsen, FW, Jones, MR, Livingston, E. Erosion of a B-Lynch suture through the uterine wall: a case report. J Reprod Med 2004; 49: 849–52.Google ScholarPubMed
49Cho, JH, Jun, HS, Lee, CN. Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstet Gynecol 2000; 96: 129–31.Google ScholarPubMed
50Ouahba, J, Piketty, M, Huel, C, Azarian, M, Feraud, O, Luton, D et al. Uterine compression sutures for postpartum bleeding with uterine atony. BJOG 2007; 114: 619–22.CrossRefGoogle ScholarPubMed
51Poujade, O, Grossetti, A, Mougel, L, Ceccaldi, P, Ducarme, G, Luton, D. Risk of synechiae following uterine compression sutures in the management of major postpartum haemorrhage. BJOG 2011; 118: 433–439.CrossRefGoogle ScholarPubMed
52Rathat, G, Do Trinh, P, Mercier, G, Reyftmann, L, Dechanet, C, Boulot, P, Giacalone, PL. Synechia after uterine compression sutures. Fertil Steril 2011; 95: 405–409.CrossRefGoogle ScholarPubMed
53Treloar, EJ, Anderson, RS, Andrews, HS, Bailey, JL. Uterine necrosis following B-Lynch suture for primary postpartum haemorrhage. BJOG 2006; 113: 486–88.CrossRefGoogle ScholarPubMed
54Wu, HH, Yeh, GP. Uterine cavity synechiae after haemostatic square suturing technique. Obstet Gynecol 2005; 105: 1176–178.CrossRefGoogle ScholarPubMed
55Reyftmann, L, Nguyen, A, Ristic, V, Rouleau, C, Mazet, N, Dechaud, H. Partial uterine wall necrosis following Cho hemostatic sutures for the treatment of postpartum hemorrhage. Gynecol Obstet Fertil 2009; 37: 579–82.CrossRefGoogle ScholarPubMed
56Mallappa Saroja, CS, Nankani, A, El-Hamamy, E. Uterine compression sutures, an update: review of efficacy, safety and complications of B-Lynch suture and other uterine compression techniques for postpartum haemorrhage. Arch Gynecol Obstet 2010; 281: 581–88.CrossRefGoogle ScholarPubMed
57Pereira, A, Nunes, F, Pedroso, S, Saraiva, J, Retto, H, Meirinho, M.Compressive uterine sutures to treat postpartum bleeding secondary to uterine atony. Obstet Gynecol 2005; 106: 569–72.CrossRefGoogle ScholarPubMed
58van den Brink, JW, Samlal, RA. Pregnancy after ligation of the hypogastric artery combined with a B-Lynch brace suture for major postpartum haemorrhage: a case with a nearly fatal outcome. Eur J Obstet Gynecol Reprod Biol 2009; 144: 187–88.CrossRefGoogle ScholarPubMed
59Mahajan, NN, Akoury, H, Sherman, C. Uterine wall partial thickness necrosis following combined B-Lynch and cho square sutures for the treatment of primary postpartum hemorrhage. J Obstet Gynaecol Can 2008; 30: 1100–1102.CrossRefGoogle Scholar
60B-Lynch, C, Coker, A, Lawal, AH, Abu, J, Cowen, MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. BJOG 1997; 104: 372–75.CrossRefGoogle ScholarPubMed
61Kayem, G, Kurinczuk, J, Alfirevic, Z, Spark, P, Brocklehurst, P, Knight, M. Specific second-line therapies for postpartum haemorrhage: a national cohort study. BJOG 2011; 118: 856–64.CrossRefGoogle ScholarPubMed
62O'Leary, JA. Uterine artery ligation in the control of postcesarean hemorrhage. J Reprod Med 1995; 40: 189–93.Google ScholarPubMed
63AbdRabbo, SA. Stepwise uterine devascularization: a novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus. Am J Obstet Gynecol 1994; 171: 694–700.CrossRefGoogle ScholarPubMed
64ACOG committee opinion. Placenta accrete. Number 266, January 2002. American College Obstetricians and Gynaecologists. Int J Gynecol Obstet 2002; 77: 77–78.CrossRefGoogle Scholar
65Knight, M.Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. BJOG 2007; 114: 1380–87.CrossRefGoogle ScholarPubMed
66Eller, A, Porter, T, Soisson, P, Silver, R. Optimal management strategies for placenta accreta. BJOG 2009; 116: 648–54.CrossRefGoogle ScholarPubMed
67Yap, YY, Perrin, LC, Pain, SR, Wong, SF, Chan, FY. Manual removal of suspected placenta accreta at cesarean hysterectomy. Int J Gynaecol Obstet 2008; 100: 186–87.CrossRefGoogle ScholarPubMed
68Stergios, KD, Arulkumaran, K. The morbidly adherent placenta: an overview of management options. Acta Obstet Gynecol 2010; 89: 1126–133.Google Scholar
69The role of emergency and elective interventional radiology in postpartum haemorrhage. In: Good practice guidance. Edited by Royal College of Obstetricians and Gynaecologists, Royal College of Radiologists, British Society of Interventional Radiology, London, 2007.Google Scholar
70Alanis, M, Hurst, BS, Marshburn, PB, Matthews, ML. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertil Steril 2006; 86: 1514–517.CrossRefGoogle Scholar
71Morgan, M, Atalla, R. Mifepristone and misoprostol for the management of placenta accreta – a new alternative approach. BJOG 2009; 116: 1002–1003.CrossRefGoogle ScholarPubMed
72Cox, SM, Carpenter, RJ, Cotton, DB. Placenta percreta: ultrasound diagnosis and conservative surgical management. Obstet Gynecol 1988; 71: 454–56.Google ScholarPubMed
73Palacios-Jaraquemada, JM, Fiorillo, A, von Petery, F, Colaci, D, Leguizamon, G. Uterine repair and successful pregnancy after myometrial and placental rupture with massive haemoperitoneum. BJOG 2009; 116: 456–60.CrossRefGoogle ScholarPubMed
74Arulkumaran, S, Ng, CS, Ingemarsson, I, Ratnam, SS. Medical treatment of placenta accreta with methotrexate. Acta Obstet Gynecol Scand 1986; 65: 285–86.CrossRefGoogle ScholarPubMed
75Gupta, D, Sinha, R. Management of placenta accreta with oral methotrexate. Int J Gynaecol Obstet 1998; 60: 171–73.CrossRefGoogle ScholarPubMed
76Mussalli, GM, Shah, J, Berck, DJ, Elimian, A, Tejani, N, Manning, FA. Placenta accreta and methotrexate therapy: three case reports. J Perinatol 2000; 20: 331–34.CrossRefGoogle ScholarPubMed
77Jaffe, R, DuBeshter, B, Sherer, DM, Thompson, EA, Woods, JR Jr. Failure of methotrexate treatment for term placenta percreta. Am J Obstet Gynecol 1994; 171: 558–59.CrossRefGoogle ScholarPubMed
78Miller, S, Fathalla, MM, Ojengbede, OA, Camlin, C, Mourad-Youssif, M, Morhason-Bello, IO et al. Obstetric hemorrhage and shock management: using the low technology Non-pneumatic Anti-Shock Garment in Nigerian and Egyptian tertiary care facilities. BMC Pregnancy Childbirth 2010; 10: 64.CrossRefGoogle ScholarPubMed
79Miller, S, Ojengbede, O, Turan, JM, Morhason-Bello, IO, Martin, HB, Nsima, D. Acomparative study of the non-pneumatic anti-shock garment for the treatment of obstetric hemorrhage in Nigeria. Int J Gynaecol Obstet 2009; 107: 121–25.CrossRefGoogle ScholarPubMed
80Ojengbede, OA, Morhason-Bello, IO, Galadanci, H, Meyer, C, Nsima, D, Camlin, C et al. Assessing the role of the non-pneumatic anti-shock garment in reducing mortality from postpartum hemorrhage in Nigeria. Gynecol Obstet Invest 2011; 71: 66–72.CrossRefGoogle ScholarPubMed
81Pelage, JP, Le Dref, O, Jacob, D, Soyer, P, Herbreteau, D, Rymer, R. Selective arterial embolization of the uterine arteries in the management of intractable post-partum hemorrhage. Acta Obstet Gynecol Scand 1999; 78: 698–703.Google ScholarPubMed
82Corr, P. Arterial embolization for haemorrhage in the obstetric patient. Baillieres Best Pract Res Clin Obstet Gynaecol 2001; 15: 557–561.CrossRefGoogle ScholarPubMed
83Ledee, N, Ville, Y, Musset, D, Mercier, F, Frydman, R, Fernandez, H. Management in intractable obstetric haemorrhage: an audit study on 61 cases. Eur J Obstet Gynecol Reprod Biol 2001; 94: 189–96.CrossRefGoogle Scholar
84Mousa, HA, Walkinshaw, S. Major postpartum haemorrhage. Curr Opin Obstet Gynecol 2001; 13: 595–603.CrossRefGoogle ScholarPubMed